Welcome to our dedicated page for Zepp Health Corporation SEC filings (Ticker: ZEPP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to Zepp Health Corporation (NYSE: ZEPP) regulatory disclosures filed with the U.S. Securities and Exchange Commission. As a foreign private issuer, Zepp Health submits annual reports on Form 20-F and current reports on Form 6-K, alongside other required documents related to its American depositary shares, each representing sixteen Class A ordinary shares.
Through these SEC filings, investors can review information about Zepp Health’s smart wearable and health technology business, which includes the Amazfit, Zepp Clarity and Zepp Aura brands. Filings such as the Form 20-F typically contain details on the company’s operations, risk factors, industry classification in electromedical and electrotherapeutic apparatus manufacturing, and corporate history, including its origin as Huami Corp. and subsequent name change to Zepp Health Corporation.
Form 6-K current reports often furnish press releases and other updates, such as announcements of unaudited quarterly financial results or other material information. For example, recent 6-K filings reference press releases regarding financial performance and confirm Zepp Health Corporation as the registrant with its principal office in Gorinchem, the Netherlands.
On this page, users can quickly locate annual reports (Form 20-F), current reports (Form 6-K) and other relevant submissions as they are made available through EDGAR. Stock Titan enhances these documents with AI-powered summaries that explain key points in accessible language, helping readers interpret complex sections on operating metrics, product portfolio, capital structure and strategic initiatives without reading every line of the original filing.
For those researching ZEPP regulatory history, this filings archive offers a structured view of how Zepp Health reports its business evolution, financial condition and risk profile over time, complementing the company’s news releases and other public communications.
Amendment No. 7 to Schedule 13G discloses that FIL Limited, Pandanus Partners, L.P. and Pandanus Associates, Inc. have completely exited their position in Zepp Health Corp (symbol ZEPP). As of the event date 31 Jul 2025, the group reports 0 Class A common shares (CUSIP CIB882000), equating to 0.0 % of the outstanding class. Consequently, the filers now fall below the 5 % reporting threshold. All voting and dispositive powers are reported as 0, and the certification confirms the securities were held in the ordinary course, not to influence control. The filing is signed 06 Aug 2025 by Richard Bourgelas under powers of attorney for each entity.
Allspring Global Investments Holdings, LLC has filed Amendment No. 7 to Schedule 13G declaring its current ownership in Zepp Health Corp (symbol ZEPP) as of 30 June 2025.
- Shares owned: 9,757,152 American Depositary Receipts (ADRs).
- Ownership percentage: 8.7 % of the outstanding ADR class, exceeding the 5 % reporting threshold.
- Voting/dispositive power: Sole voting power and sole dispositive power over the entire position; no shared power reported.
- Holder classification: Designated as a Holding Company/Control person (Item 3 — HC).
- Stake origin: Securities are held for clients of subsidiaries Allspring Global Investments, LLC and Allspring Funds Management, LLC; no single client holds more than 5 % of the class.
- Intent statement: Filing certifies the position was acquired in the ordinary course of business and not to influence control of Zepp Health.
- Signatories & dates: Event date 06-30-2025; filing signed by Senior Compliance Manager Jennifer Grunberg on 07-14-2025.
This disclosure signals a sizeable passive institutional position in Zepp Health, potentially viewed by the market as a vote of confidence in the company’s prospects without implying activist intentions.